Premium
Hospital clinical staging accuracy for upper gastrointestinal malignancy
Author(s) -
Costa Wilson Luiz,
Tran Cao Hop S.,
Portuondo Jorge I.,
Sada Yvonne H.,
Massarweh Nader N.
Publication year - 2020
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.26211
Subject(s) - medicine , stage (stratigraphy) , malignancy , pancreas , cancer staging , radiology , pancreatic cancer , esophagus , cohort , cancer , esophageal cancer , t stage , paleontology , biology
Background Decisions about multimodality treatment for upper gastrointestinal malignancies are largely predicted on clinical staging information. However, hospital‐level accuracy of clinical staging is currently unknown. Methods A national cohort study of patients with adenocarcinoma of the esophagus, stomach, or pancreas in the NCDB (2006–2015) who were treated with upfront resection. Hospital‐level staging accuracy (ascertained by comparing clinical stage to pathologic stage) was calculated. Within hospital correlation of staging accuracy across disease sites was evaluated using risk and reliability adjustment. Results Overall, 1246 hospitals were evaluated. Median hospital T‐staging accuracy was 77.5%, 73.7%, and 60.8% for esophageal, gastric, and pancreatic cancer, respectively. Median hospital N‐staging accuracy was 80.2%, 72.9%, and 61.8%, respectively. For T‐stage, over‐staging was most frequently observed in esophageal patients (11.2%) while under‐staging was most frequent in pancreatic patients (36.1%). For N‐stage, over‐staging was infrequent for all three, while under‐staging was most common in pancreatic patients (37.4%). Correlation across disease sites was weak for both T‐ (best observed, r = .34) and N‐stages ( r = .30). When high volume hospitals were evaluated, correlation improved but accuracy rates were similar. Conclusions Despite the importance of clinical staging in multimodality treatment planning, hospitals inaccurately stage 20–40% of patients, with low correlation across disease sites.